
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
Higgins, Eleanor, Al Shehri, Tariq, McAleer, Maeve A., Conlon, Niall, Feighery, Conleth, Lilic, Desa, Irvine, Alan D.Volume:
135
Langue:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2014.12.1867
Date:
February, 2015
Fichier:
PDF, 869 KB
english, 2015